LYDIA MORRISON: Open Payments
NPI 1780236232 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 7 payments from 6 companies in 2025. Trend: 2023 $236 · 2024 $159 · 2025 $327
Food & beverage: $249Education: $78
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $118 |
| SEAGEN INC. | 1 | $78 |
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| Astellas Pharma US Inc | 1 | $27 |
| Tactile Systems Technology Inc | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: JEMPERLI, LYNPARZA, Veozah, Flexitouch Plus, MYFEMBREE.
Industry payments across NV — which companies pay providers there.
